Rating History for Enanta Pharmaceuticals (ENTA) by Rodman & Renshaw
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/26/2026 | Seema Sheoran | New Coverage | Buy (N/A) |
20.00 (N/A) |
12.17 (14.06) |
15.53% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/26/2026 | Seema Sheoran | New Coverage | Buy (N/A) |
20.00 (N/A) |
12.17 (14.06) |
15.53% | Details |